PT UBC (Indonesia) Performance

LABS Stock   128.00  2.00  1.59%   
The company owns a Beta (Systematic Risk) of -0.0638, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning PT UBC are expected to decrease at a much lower rate. During the bear market, PT UBC is likely to outperform the market. At this point, PT UBC Medical has a negative expected return of -0.18%. Please make sure to check PT UBC's standard deviation, jensen alpha, and the relationship between the coefficient of variation and information ratio , to decide if PT UBC Medical performance from the past will be repeated at some future date.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PT UBC Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's forward-looking signals remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors. ...more
  

PT UBC Relative Risk vs. Return Landscape

If you would invest  14,200  in PT UBC Medical on August 30, 2024 and sell it today you would lose (1,600) from holding PT UBC Medical or give up 11.27% of portfolio value over 90 days. PT UBC Medical is generating negative expected returns and assumes 1.6328% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than LABS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon PT UBC is expected to under-perform the market. In addition to that, the company is 2.12 times more volatile than its market benchmark. It trades about -0.11 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

PT UBC Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for PT UBC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PT UBC Medical, and traders can use it to determine the average amount a PT UBC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.108

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsLABS

Estimated Market Risk

 1.63
  actual daily
14
86% of assets are more volatile

Expected Return

 -0.18
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average PT UBC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PT UBC by adding PT UBC to a well-diversified portfolio.

Things to note about PT UBC Medical performance evaluation

Checking the ongoing alerts about PT UBC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PT UBC Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
PT UBC Medical generated a negative expected return over the last 90 days
Evaluating PT UBC's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate PT UBC's stock performance include:
  • Analyzing PT UBC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PT UBC's stock is overvalued or undervalued compared to its peers.
  • Examining PT UBC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating PT UBC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PT UBC's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of PT UBC's stock. These opinions can provide insight into PT UBC's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating PT UBC's stock performance is not an exact science, and many factors can impact PT UBC's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.